thought leadership
Access for Cell and Gene Therapies in the Asia Pacific Region: exploring new horizons
March 15, 2024
In the Asia-Pacific (APAC) region, the demand for cell and gene therapies (CGTs) is increasing but the reimbursement environment for these therapies is still nascent.
This report delves into the CGT landscape in the APAC region. It examines market access dynamics for both global and local CGT products and uncovers the crucial factors that manufacturers need to consider to optimize CGT access in APAC.
The report includes expert insights on:
- The evolving APAC cell and gene therapy regulatory and reimbursement landscape
- The CGT capabilities of local biotechs in APAC and where their products are today
- Global learnings for overcoming hurdles to optimal CGTs access can be adapted for the APAC region
- Critical considerations for building the necessary ecosystems to successfully deploy CGTs in the APAC region
